Player Michael J, Taylor Janet L, Weickert Cynthia Shannon, Alonzo Angelo, Sachdev Perminder S, Martin Donel, Mitchell Philip B, Loo Colleen K
School of Psychiatry, University of New South Wales, Sydney, Australia; Black Dog Institute, Hospital Road, Randwick, Sydney, NSW 2031, Australia.
Neuroscience Research Australia, Sydney, Australia; School of Medical Sciences, University of New South Wales, Sydney, Australia.
J Affect Disord. 2014;167:140-7. doi: 10.1016/j.jad.2014.05.063. Epub 2014 Jun 6.
Several lines of evidence suggest that neuroplasticity is impaired in depression and improves with effective treatment. However until now, this evidence has largely involved measures such as learning and memory which can be influenced by subject effort and motivation. This pilot study aimed to objectively measure neuroplasticity in the motor cortex using paired associative stimulation (PAS), which induces short term neuroplastic changes. It is hypothesized that neuroplasticity would improve after effective treatment for depression.
Neuroplasticity was measured in 18 depressed subjects before and after a course of anodal transcranial direct current stimulation (tDCS), given as treatment for depression. The relationships between PAS results, mood state and brain-derived neurotrophic factor (BDNF) serum levels were examined.
Neuroplasticity (PAS-induced change) was increased after a course of tDCS (t(17)=-2.651, p=0.017). Treatment with tDCS also led to significant mood improvement, but this did not correlate with improved neuroplasticity. Serum BDNF levels did not change after tDCS, or correlate with change in neuroplasticity after tDCS treatment.
While this study showed evidence of improved neuroplasticity in the motor cortex after effective treatment, we are unable to present evidence that this change is generalized in the depressed brain. Also, the presence of antidepressant medications and the small sample of patients (n=18) meant the study could not definitively resolve the relationship between neuroplasticity, mood and BDNF.
This novel preliminary study provides evidence that a treatment course of tDCS can improve neuroplasticity in depressed patients.
多项证据表明,抑郁症患者存在神经可塑性受损的情况,而有效的治疗可使其改善。然而,迄今为止,这些证据主要涉及学习和记忆等受受试者努力程度和动机影响的指标。本初步研究旨在使用配对联想刺激(PAS)客观测量运动皮层的神经可塑性,PAS可诱导短期神经可塑性变化。研究假设,抑郁症经有效治疗后神经可塑性会得到改善。
对18名抑郁症患者在接受阳极经颅直流电刺激(tDCS)治疗抑郁症的疗程前后测量其神经可塑性。研究了PAS结果、情绪状态和脑源性神经营养因子(BDNF)血清水平之间的关系。
经过一个疗程的tDCS治疗后,神经可塑性(PAS诱导的变化)增强(t(17)= -2.651,p = 0.017)。tDCS治疗还显著改善了情绪,但这与神经可塑性的改善无关。tDCS治疗后血清BDNF水平未发生变化,也与tDCS治疗后神经可塑性的变化无关。
虽然本研究显示了有效治疗后运动皮层神经可塑性改善的确切证据,但我们无法证明这种变化在抑郁症患者大脑中具有普遍性。此外,抗抑郁药物的存在以及患者样本量较小(n = 18)意味着该研究无法明确解决神经可塑性、情绪和BDNF之间的关系。
这项新颖的初步研究提供了证据,表明一个疗程的tDCS治疗可改善抑郁症患者的神经可塑性。